BASECARE-B

2170
1.3352.55% ( -0.035 )
Delay Closed: Nov 16, 16:08:00

Valuation

Current ValuationThe current P/E ratio is -1.82, above the reasonable range, cheaper than 9.36% of the time in the past 5 years, and the industry ranks 9/12, the industry Median 9.30.

-1.82xP/E
Stock priceHK$1.34Earnings per shareHK$-0.73

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 9.30x
07142128

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 9.30x
0x10x20x30x40x50x
P/E ratio
Name/Symbol
02170HKBASECARE-B
-1.82x27.39%HK$364.39M
08622HKJOYZYME GROUP
-26.50x--HK$152.06M
00876HKQH BIO PHARMA
-1.53x--HK$151.30M
02393HKYESTAR HEALTH
-1.18x--HK$114.25M
01134HKKELFRED
-4.59x--HK$102.50M
08513HKMAXWIN INT HLDG
-10.65x--HK$26.19M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.